Literature DB >> 16566899

The mesolimbic dopamine reward circuit in depression.

Eric J Nestler1, William A Carlezon.   

Abstract

The neural circuitry that mediates mood under normal and abnormal conditions remains incompletely understood. Most attention in the field has focused on hippocampal and frontal cortical regions for their role in depression and antidepressant action. While these regions no doubt play important roles in these phenomena, there is compelling evidence that other brain regions are also involved. Here we focus on the potential role of the nucleus accumbens (NAc; ventral striatum) and its dopaminergic input from the ventral tegmental area (VTA), which form the mesolimbic dopamine system, in depression. The mesolimbic dopamine system is most often associated with the rewarding effects of food, sex, and drugs of abuse. Given the prominence of anhedonia, reduced motivation, and decreased energy level in most individuals with depression, we propose that the NAc and VTA contribute importantly to the pathophysiology and symptomatology of depression and may even be involved in its etiology. We review recent studies showing that manipulations of key proteins (e.g. CREB, dynorphin, BDNF, MCH, or Clock) within the VTA-NAc circuit of rodents produce unique behavioral phenotypes, some of which are directly relevant to depression. Studies of these and other proteins in the mesolimbic dopamine system have established novel approaches to modeling key symptoms of depression in animals, and could enable the development of antidepressant medications with fundamentally new mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16566899     DOI: 10.1016/j.biopsych.2005.09.018

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  724 in total

Review 1.  The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward?

Authors:  Patrick H Finan; Bethany Remeniuk; Kelly E Dunn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-01       Impact factor: 5.067

2.  Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.

Authors:  Anita J Bechtholt-Gompf; Hali V Walther; Martha A Adams; William A Carlezon; Dost Ongür; Bruce M Cohen
Journal:  Neuropsychopharmacology       Date:  2010-06-09       Impact factor: 7.853

3.  Shared genetic factors influence risk for bipolar disorder and alcohol use disorders.

Authors:  N Carmiol; J M Peralta; L Almasy; J Contreras; A Pacheco; M A Escamilla; E E M Knowles; H Raventós; D C Glahn
Journal:  Eur Psychiatry       Date:  2013-12-08       Impact factor: 5.361

4.  Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior.

Authors:  Sade Spencer; Edgardo Falcon; Jaswinder Kumar; Vaishnav Krishnan; Shibani Mukherjee; Shari G Birnbaum; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

5.  Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state.

Authors:  Yossef Goffer; Duo Xu; Sarah E Eberle; James D'amour; Michelle Lee; David Tukey; Robert C Froemke; Edward B Ziff; Jing Wang
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

Review 6.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

7.  Regulatory mechanisms of fear extinction and depression-like behavior.

Authors:  Natalie C Tronson; Christina Schrick; Andre Fischer; Farahnaz Sananbenesi; Gilles Pagès; Jacques Pouysségur; Jelena Radulovic
Journal:  Neuropsychopharmacology       Date:  2007-08-22       Impact factor: 7.853

8.  Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.

Authors:  Doug Hyun Han; Sun Mi Kim; Jung Eun Choi; Kyung Joon Min; Perry F Renshaw
Journal:  J Psychopharmacol       Date:  2013-01-16       Impact factor: 4.153

9.  A neural pathway controlling motivation to exert effort.

Authors:  Christophe D Proulx; Sage Aronson; Djordje Milivojevic; Cris Molina; Alan Loi; Bradley Monk; Steven J Shabel; Roberto Malinow
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-11       Impact factor: 11.205

10.  Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood.

Authors:  Sergio D Iñiguez; Lyonna F Alcantara; Brandon L Warren; Lace M Riggs; Eric M Parise; Vincent Vialou; Katherine N Wright; Genesis Dayrit; Steven J Nieto; Matthew B Wilkinson; Mary K Lobo; Rachael L Neve; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.